期刊文献+

慢性乙型重型肝炎预后的危险因素相关性分析 被引量:6

Study the risk factors influencing the prognosis of chronic severe hepatitis B
原文传递
导出
摘要 目的探讨影响慢性乙型重型肝炎患者预后的危险因素。方法收集浙江大学医学院附属第一医院345例慢性乙型重型肝炎患者临床资料,根据治疗结果分为好转组和恶化组,回顾性分析患者9项临床资料与预后间的相关性。结果患者年龄、重叠其他病毒感染、有无合并肝硬化以及是否抗病毒治疗2组间差异有统计学意义(P<0.05),而患者性别、嗜烟酒、并发糖尿病和高血压等因素在2组间差异无统计学意义(P>0.05)。结论年龄较大,重叠其他病毒感染,有肝硬化基础及未经抗毒治疗的慢性乙型重型肝炎患者预后较差。 Objective To study the risk factors influencing the prognosis of chronic severe hepatitis B. Method Three hundreds and forty-five patients with chronic severe hepatitis B were divided into improved group and aggravated group.Nine clinical and laboratory parameters were collected as predictive risk factors.The relationships between risk factors and chronic severe hepatitis B were analyzed retrospectively. Result Some reanses as the ages,co-infection and anti-viral treatment were significant different between the two groups(P〈0.05).However,the sex,smoking,drinking,diabetes mellitus and hypertension were not significant different(P〉0.05). Conclusion There are some risk reasons of chronic hepatitis with older,coninfectiong with other hepatitis virus,hepatic cirrhosis and non-anti-viral treatment.
出处 《中国微生态学杂志》 CAS CSCD 2011年第3期255-256,共2页 Chinese Journal of Microecology
关键词 重型肝炎 乙肝 预后 危险因素 Severe hepatitis; Hepatitis B; Prognosis; Risk factor
  • 相关文献

参考文献7

二级参考文献102

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2张龄霞 骆抗先.乙型病毒性肝炎[A].见:陈菊梅主编.现代传染病学[C].北京:人民军医出版社,1999.249-269.
  • 3DHIMAN RK, SETH AK, JAIN S, et al. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis [J] . Dig Dis Sci, 1998, 43:1311 -1316.
  • 4Lee KM, Cho SW, Kim SW, et al. Effect of virological response on post - treatment durability of lamivudine - induced HBeAg seroconversion [ J ]. J Viral Hepat,2002,9 ( 3 ) : 208 - 212.
  • 5Liaw YF, Leung NW, Chang TT, et al. Effects of extended tamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group [ J ]. Gastroenterology, 2000,119 ( 1 ) : 172 - 180.
  • 6Leung NW, Lai CL, Chang TF, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy [ J ]. Hepatology ,2001,33(6): 1527 - 1532.
  • 7Liaw YF, Leung N, Kao JH, et al. Asian - Pacific consensus statement on the management of chronic hepatitis B : a 2008 update [ J ]. Hepatol Int,2008,2 ( 3 ) : 263 - 283.
  • 8European Association For The Study of The Liver. EASL Clinical Practice Guidelines : management of chronic hepatitis B [ J ]. J Hepatol,2009,50 (2) : 227 - 242.
  • 9Lok AS, McMahon BJ. Chronic hepatitis B: update 2009 [ J]. Hepatology ,2009,50( 3 ) : 661 -662.
  • 102006年全国人群乙肝血清流行病学调查结果[R].卫生部疾病控制专题新闻发布会:http://www.gov.cn/xwfb/2008—04/21/content950425.htm.

共引文献1939

同被引文献56

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部